RxSight, Inc. (RXST)
Total Valuation
RxSight has a market cap or net worth of $553.92 million. The enterprise value is $492.35 million.
Market Cap | 553.92M |
Enterprise Value | 492.35M |
Important Dates
The next earnings date is Thursday, May 4, 2023, after market close.
Estimated Earnings Date | May 4, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
RxSight has 33.78 million shares outstanding. The number of shares has increased by 103.02% in one year.
Shares Outstanding | 33.78M |
Shares Change (YoY) | +103.02% |
Shares Change (QoQ) | +1.19% |
Owned by Insiders (%) | 17.82% |
Owned by Institutions (%) | 41.89% |
Float | 20.50M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 11.30 |
Forward PS | 5.17 |
PB Ratio | 6.16 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 10.05 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.81, with a Debt / Equity ratio of 0.50.
Current Ratio | 7.81 |
Quick Ratio | 6.82 |
Debt / Equity | 0.50 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -63.70% and return on invested capital (ROIC) is -35.30%.
Return on Equity (ROE) | -63.70% |
Return on Assets (ROA) | -41.10% |
Return on Capital (ROIC) | -35.30% |
Revenue Per Employee | $221,742 |
Profits Per Employee | -$302,063 |
Employee Count | 221 |
Asset Turnover | 0.30 |
Inventory Turnover | 2.42 |
Taxes
In the past 12 months, RxSight has paid $9,000 in taxes.
Income Tax | 9,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.75% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | +33.75% |
50-Day Moving Average | 14.09 |
200-Day Moving Average | 13.33 |
Average Volume (30 Days) | 138,456 |
Short Selling Information
The latest short interest is 400,099, so 1.18% of the outstanding shares have been sold short.
Short Interest | 400,099 |
Short Previous Month | 405,232 |
Short % of Shares Out | 1.18% |
Short % of Float | 1.95% |
Short Ratio (days to cover) | 2.80 |
Income Statement
In the last 12 months, RxSight had revenue of $49.01 million and -$66.76 million in losses. Loss per share was -$2.41.
Revenue | 49.01M |
Gross Profit | 21.33M |
Operating Income | -63.32M |
Pretax Income | -66.75M |
Net Income | -66.76M |
EBITDA | -57.78M |
EBIT | -61.80M |
Loss Per Share | -$2.41 |
Balance Sheet
The company has $106.56 million in cash and $45.00 million in debt, giving a net cash position of $61.57 million or $1.82 per share.
Cash & Cash Equivalents | 106.56M |
Total Debt | 45.00M |
Net Cash | 61.57M |
Net Cash Per Share | $1.82 |
Equity / Book Value | 89.90M |
Book Value Per Share | 2.66 |
Working Capital | 117.32M |
Cash Flow
In the last 12 months, operating cash flow was -$58.85 million and capital expenditures -$2.39 million, giving a free cash flow of -$61.24 million.
Operating Cash Flow | -58.85M |
Capital Expenditures | -2.39M |
Free Cash Flow | -61.24M |
FCF Per Share | -$2.21 |
Margins
Gross margin is 43.52%, with operating and profit margins of -129.21% and -136.22%.
Gross Margin | 43.52% |
Operating Margin | -129.21% |
Pretax Margin | -136.20% |
Profit Margin | -136.22% |
EBITDA Margin | -117.90% |
EBIT Margin | -126.11% |
FCF Margin | -124.97% |
Dividends & Yields
RxSight does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -12.05% |
FCF Yield | -11.06% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -103.02% |
Shareholder Yield | -103.02% |
Analyst Forecast
The average price target for RxSight is $19.79, which is 20.67% higher than the current price. The consensus rating is "Buy".
Price Target | $19.79 |
Price Target Difference | 20.67% |
Analyst Consensus | Buy |
Analyst Count | 11 |
Revenue Growth Forecast (5Y) | 36.77% |
EPS Growth Forecast (5Y) | -25.96% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |